These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 6352667)

  • 41. Disopyramide in acute myocardial infarction: problems with changing pharmacokinetics.
    Elliott HL; Thomson AH; Bryson SM
    Eur J Clin Pharmacol; 1986; 30(3):345-7. PubMed ID: 3732373
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Disopyramide: its mechanisms of action and clinical use].
    Härtel G
    Kardiologiia; 1985 Nov; 25(11):113-6. PubMed ID: 3910910
    [No Abstract]   [Full Text] [Related]  

  • 43. Göteborg Metoprolol Trial: design, patient characteristics and conduct.
    Herlitz J; Holmberg S; Pennert K; Swedberg K; Vedin A; Waagstein F; Waldenström A; Waldenström J; Wedel H; Wilhelmsen L
    Am J Cardiol; 1984 Jun; 53(13):3D-8D. PubMed ID: 6731326
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Effect of intravenous disopyramide in supraventricular paroxysmal tachycardia refractory to vagal maneuvers].
    Romero-Ayala LC; Soní J
    Arch Inst Cardiol Mex; 1983; 53(2):147-51. PubMed ID: 6882095
    [TBL] [Abstract][Full Text] [Related]  

  • 45. QT dispersion as a predictor of long-term mortality in patients with acute myocardial infarction and clinical evidence of heart failure.
    Spargias KS; Lindsay SJ; Kawar GI; Greenwood DC; Cowan JC; Ball SG; Hall AS
    Eur Heart J; 1999 Aug; 20(16):1158-65. PubMed ID: 10448024
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Intravenously disopyramide phosphate administration for treatment of arrhythmias].
    Aquaro G; Belli R; Pavia M; Rey L; Ravera A; Possavino G; Idone P
    G Ital Cardiol; 1982; 12(7):509-19. PubMed ID: 7169147
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The pharmacokinetics of disopyramide in patients with acute myocardial infarction.
    Jounela AJ; Pentikäinen PJ; Oksanen K
    Int J Clin Pharmacol Ther Toxicol; 1982 Jun; 20(6):276-82. PubMed ID: 7107076
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Relation between electrocardiographic ST-segment resolution and early and late outcomes after primary percutaneous coronary intervention for acute myocardial infarction.
    Brodie BR; Stuckey TD; Hansen C; VerSteeg DS; Muncy DB; Moore S; Gupta N; Downey WE
    Am J Cardiol; 2005 Feb; 95(3):343-8. PubMed ID: 15670542
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Prevention of arrhythmias in myocardial infarct with disopyramide].
    Selvini A
    Minerva Med; 1970 Sep; 61(71 Suppl):3774-6. PubMed ID: 5454443
    [No Abstract]   [Full Text] [Related]  

  • 50. [Magnesium sulfate in acute myocardial infarction].
    Balli E; Giomi A; Del Citerna F
    G Ital Cardiol; 1995 Nov; 25(11):1425-32. PubMed ID: 8682239
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Disopyramide kinetics in patients with acute myocardial infarction.
    Ilett KF; Madsen BW; Woods JD
    Clin Pharmacol Ther; 1979 Jul; 26(1):1-7. PubMed ID: 445953
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Efficacy and tolerability of sustained-release disopyramide in the treatment of cardiac arrhythmia. Results of a study with 593 patients].
    Lekieffre J; Vaur L; Kacet S; Lacroix D
    Ann Cardiol Angeiol (Paris); 1993 Feb; 42(2):115-9. PubMed ID: 8494319
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Cardiac rhythm disorders after pneumonectomy. Attempted prevention].
    Berthoumieu F; Henry E; Glovaez D; Desrez X; Pradere B; Fournial G; Gaillard J
    Poumon Coeur; 1978; 34(1):49-52. PubMed ID: 643778
    [No Abstract]   [Full Text] [Related]  

  • 54. Use of nitrates in patients with acute myocardial infarction.
    Stratton MA
    Clin Pharm; 1984; 3(1):32-9. PubMed ID: 6421532
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Disopyramide: interactions with marcolide antibiotics.
    Prescrire Int; 2001 Oct; 10(55):151. PubMed ID: 11824433
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Acute effects of conventional oral dose of disopyramide on left atrial and ventricular functions.
    Arakawa M; Miwa H; Noda T; Kagawa K; Nishigaki K; Ito Y; Kawada T; Hirakawa S
    Int J Clin Pharmacol Ther Toxicol; 1993 May; 31(5):253-9. PubMed ID: 8314654
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Long-term effects of thrombolytic therapy on clinical course and left ventricular function after acute myocardial infarction.
    Goyal SP; Wahal PK; Gupta MC; Garg P; Pandy DN
    J Assoc Physicians India; 1994 Jan; 42(1):16-9. PubMed ID: 7836239
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Anti-arrhythmic effect of oral propafenone. Apropos of 70 cases].
    Coumel P; Leclercq JF; Assayag P; Maisonblanche P; Cauchemez B
    Arch Mal Coeur Vaiss; 1984 Nov; 77(12):1370-82. PubMed ID: 6439161
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Magnesium and acute myocardial infarction.
    Mitchell C
    West J Med; 1991 Sep; 155(3):285. PubMed ID: 1949778
    [No Abstract]   [Full Text] [Related]  

  • 60. Disopyramide in myocardial infarction.
    Kidner PH; Besterman EM
    Lancet; 1978 Mar; 1(8063):562. PubMed ID: 76109
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.